TFAP

CAS No. 1011244-68-0

TFAP( TFAP )

Catalog No. M19375 CAS No. 1011244-68-0

TFAP is a selective cyclooxygenase-1 (COX-1) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 44 In Stock
5MG 41 In Stock
10MG 65 In Stock
25MG 124 In Stock
50MG 221 In Stock
100MG 328 In Stock
200MG 458 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TFAP
  • Note
    Research use only, not for human use.
  • Brief Description
    TFAP is a selective cyclooxygenase-1 (COX-1) inhibitor.
  • Description
    TFAP is a cell-permeable pyridinyl-benzamide compound that acts as a COX-1-selective inhibitor by targeting the enzyme's active site. TFAP displays analgesic properties in mice and rats in vivo without long-term cytotoxic effects. Unlike COX-2-inhibiting analgesics such as aspirin, TFAP is shown not to cause gastric damage in rats in vivo.
  • In Vitro
    TFAP is a selective cyclooxygenase-1 (COX-1) inhibitor, with an IC50 of 0.8 μM, while that against COX-2 is over 200 μM.
  • In Vivo
    ——
  • Synonyms
    TFAP
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX-1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1011244-68-0
  • Formula Weight
    281.23
  • Molecular Formula
    C13H10F3N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 155 mg/mL; 551.15 mM
  • SMILES
    O=C(Nc1ccc(N)cn1)c2ccc(cc2)C(F)(F)F
  • Chemical Name
    N-(5-amino-2-pyridinyl)-4-(trifluoromethyl)-benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kakuta H, et al. Identification of urine metabolites of TFAP, a cyclooxygenase-1 inhibitor. Bioorg Med Chem Lett. 2010 Mar 15;20(6):1840-3.
molnova catalog
related products
  • 2-Amino-5-methyl-3-t...

    It is an organic compunds with molecular fomula C6H6N2S.

  • hCYP3A4 Fluorogenic ...

    hCYP3A4 Fluorogenic substrate 1, a phthalimide derivative, exhibits low activity against COX.

  • Chebulagic acid

    Chebulagic acid, isolated from the Terminalia chebula Retz, is a COX-LOX dual inhibitor.Chebulagic acid can enhance autophagy and exerts anti-inflammatory and anti-infective effects.